38600 Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) 

Laboratory Test Result Form ................................................................................................. 754 2 10/60 

Dated: July 9, 2007. 

Maryam Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–13605 Filed 7–12–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Childhood 

Lead Poisoning Prevention (ACCLPP), 

National Center for Environmental 

Health (NCEH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following meeting of the 

aforementioned committee: 

Times and Dates: 

8:30 a.m.–5 p.m., September 18, 2007. 

8:30 a.m.–12:30 p.m., September 19, 2007. 

Place: Radisson Plaza Hotel Minneapolis, 

35 South 7th Street, Minneapolis, MN 55402, 

Telephone: (612) 339–4900. 

Open to the public, limited only by the 

space available. The meeting room 

accommodates approximately 75 people. 

Purpose: The Committee provides advice 

and guidance to the Secretary; the Assistant 

Secretary for Health; and the Director, CDC, 

regarding new scientific knowledge and 

technological developments and their 

practical implications for childhood lead 

poisoning prevention efforts. The Committee 

also reviews and reports regularly on 

childhood lead poisoning prevention 

practices and recommends improvements in 

national childhood lead poisoning 

prevention efforts. 

Matters To Be Discussed: The meeting will 

include discussion on the potential 

approaches to strengthen existing strategies 

to achieve the Healthy People 2010 goal of 

eliminating Elevated Blood Lead Levels as a 

Public Health Problem in the United States 

by 2010, the development of a prevention 

based research agenda, and the study designs 

related to adverse effects from Blood Lead 

Levels (BLLs) < 10 μg/dl; and updates on the 

school performance and concurrent BLLs. 

Agenda items are subject to change as 

priorities dictate. 

Opportunities will be provided during the 

meeting for oral comments. Depending on the 

time available and the number of requests, it 

may be necessary to limit the time of each 

presenter. 

Contact Person for More Information: 

Claudine Johnson, Clerk, Lead Poisoning 

Prevention Branch, Division of 

Environmental Emergency Health Services, 

NCEH, CDC, 4770 Buford Hwy, NE., Mailstop 

F–40, Atlanta, GA 30341, Telephone (770) 

488–3629, Fax (770) 488–3635. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: July 6, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–13596 Filed 7–12–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Racial and Ethnic 

Approaches to Community Health 

Across the United States (REACH US), 

Request for Applications (RFA) DP07–

707 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Public Law 92–463), the Centers for 

Disease Control and Prevention (CDC) 

announces a meeting of the 

aforementioned Special Emphasis 

Panel. 

Times and Dates: 3 p.m.–8 p.m., July 31, 

2007 (Closed), 8 a.m.–5 p.m., August 1, 2007 

(Closed), 8 a.m.–5 p.m., August 2, 2007 

(Closed), 3 p.m.–8 p.m., August 6, 2007 

(Closed), 8 a.m.–5 p.m., August 7, 2007 

(Closed), 8 a.m.–5 p.m., August 8, 2007 

(Closed), 8 a.m.–5 p.m., August 9, 2007 

(Closed). 

Place: Sheraton Gateway Hotel Atlanta 

Airport, 1900 Sullivan Road, Atlanta, GA 

30337, Telephone (800) 454–6835. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Pub. L. 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of research grant applications in 

response to RFA DP07–707, ‘‘Racial and 

Ethnic Approaches to Community Health 

Across the United States (REACH US).’’

For Further Information Contact: Thijuanie 

Lockhart, Program & Management Analyst, 

CDC, 4770 Buford Highway, NE., Mail Stop 

K–30, Atlanta, GA 30341, Telephone (404) 

488–5303. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: July 9, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–13602 Filed 7–12–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–67776, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 72 FR 35491–35492, 

dated June 28, 2007) is amended to 

reflect the establishment of the 

Extramural Research Program Office 

within the National Center for Chronic 

Disease Prevention and Health 

Promotion, Coordinating Center for 

Health Promotion, Centers for Disease 

Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: After the functional statement 

for the Program Services Branch 

(CUC13), Office of the Director (CUC1), 

National Center for Chronic Disease 

Prevention and Health Promotion 

(CUC), insert the following: 

Extramural Research Program Office 

(CUC18). The Extramural Research 

Program Office (ERPO) plans, develops, 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices 38601 

coordinates, and evaluates extramural 

research activities in cooperation with 

centers, divisions, and offices within the 

Coordinating Center for Health 

Promotion. In carrying out its mission, 

the ERPO: (1) Coordinates, monitors, 

and directs the extramural research 

program which is designed to address 

center priorities; (2) provides scientific 

leadership in the processes supporting 

extramural research of the center; (3) 

works with National Centers to prepare 

and promote initiatives to stimulate 

extramural research in relevant priority 

areas; (4) coordinates and conducts indepth external peer review and 

secondary program relevance review of 

extramural research applications by use 

of consultant expert panels; (5) makes 

recommendations to the center directors 

on award selections on the basis of 

secondary reviews; (6) staff members 

serve as the program officials and work 

with CDC grants management officers, 

and the Procurement and Grants Office 

to implement and monitor the scientific, 

technical, and administrative aspects of 

awards; (7) facilitates scientific 

collaborations between external and 

internal investigators; (8) evaluates 

extramural research progress and impact 

and disseminates findings; and (9) 

assists Office of the Chief Science 

Officer, CDC, in developing extramural 

research policies and oversees the 

implementation of those policies within 

the center. 

Dated: June 28, 2007. 

William H. Gimson, 

Chief Operating Officer, Centers for Disease 

Control and Prevention (CDC). 

[FR Doc. 07–3427 Filed 7–12–07; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10137, CMS–

10237 and 10214, CMS–10242, CMS–379 

and CMS–10102] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Application for 

Prescription Drug Plans (PDP); 

Application for Medicare Advantage 

Prescription Drug (MA–PD); 

Application for Cost Plans to Offer 

Qualified Prescription Drug Coverage; 

Application for Employer Group Waiver 

Plans to Offer Prescription Drug 

Coverage; Service Area Expansion 

Application for Prescription Drug 

Coverage; Use: Collection of this 

information is mandated in Part D of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003. The application requirements are 

codified in Subpart K of 42 CFR 423. 

Coverage for the prescription drug 

benefit is provided through prescription 

drug plans (PDPs) that offer drug-only 

coverage, or through Medicare 

Advantage (MA) organizations that offer 

integrated prescription drug and health 

care coverage (MA–PD plans). PDPs 

must offer a basic drug benefit. 

Medicare Advantage Coordinated Care 

Plans (MA–CCPs) must offer either a 

basic benefit or may offer broader 

coverage for no additional cost. 

Medicare Advantage Private Fee for 

Service Plans (MA–PFFS) may choose to 

offer a Part D benefit. Cost Plans that are 

regulated under Section 1876 of the 

Social Security Act, and Employer 

Group Plans may also provide a Part D 

benefit. If any of the contracting 

organizations meet basic requirements, 

they may also offer supplemental 

benefits through enhanced alternative 

coverage for an additional premium. 

The information will be collected 

under the solicitation of proposals from 

PDP, MA–PD, Cost Plan, and Employer 

Group Waiver Plans applicants. The 

collected information will be used by 

CMS to: (1) Insure that applicants meet 

CMS requirements, and (2) support the 

determination of contract awards. 

Refer to the ‘‘High-Level Summary of 

Changes in Employer Group Waiver 

Plan Part D Applications’’ and ‘‘HighLevel Summary of All Part D 

Application Revisions from 2008 

Solicitation for the 2009 Solicitation’’

documents to review changes from 2008 

to 2009; Form Number: CMS–10137 

(OMB#: 0938–0936); Frequency: 

Reporting: Once; Affected Public: 

Business or other for-profit and Not-forprofit institutions; Number of 

Respondents: 455; Total Annual 

Responses: 455; Total Annual Hours: 

11,890. 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicare 

Advantage (MA) Applications—Part C; 

Use: An entity seeking a contract as an 

MA organization must be able to 

provide Medicare’s basic benefits plus 

meet the organizational requirements set 

out in regulations at 42 CFR part 422. 

An applicant must demonstrate that it 

can meet the benefit and other 

requirements within the specific 

geographic area it is requesting. The 

application forms are designed to give 

CMS the information they need about 

the health plan to determine compliance 

with Federal regulations at 42 CFR part 

422 in an efficient manner. The cited 

regulations outline the MA application 

process that begins with submission of 

an application in the form and manner 

that the Secretary provides. The MA 

application forms will be used by CMS 

to determine whether an entity is 

eligible to enter into a contract to 

provide services to Medicare 

beneficiaries. Refer to the ‘‘2009 

Medicare Advantage Application 

Changes’’ document to review a list of 

the 2009 changes. Form Number: CMS–

10237 and 10214 (OMB#: 0938–0935); 

Frequency: Reporting: Yearly; Affected 

Public: Business or other for-profit and 

Not-for-profit institutions; Number of 

Respondents: 241; Total Annual 

Responses: 241; Total Annual Hours: 

5,858. 

3. Type of Information Collection 

Request: New collection; Title of 

Information Collection: Revisions to 

Payment Policies Under the Physician 

Fee Schedule, Other Changes to 

Payment Under Part B, and Revisions to 

Payment Policies for Ambulance 

Services for CY 2008 (42 CFR 424.36—

Signature Requirements); Use: 42 CFR 

424.33(a)(3) states that all claims must 

be signed by the beneficiary or the 

beneficiary’s representative (in 

accordance with 42 CFR 424.36(b)). 42 

CFR 424.36(a) states that the 

beneficiary’s signature is required on a 

claim unless the beneficiary has died or 

the provisions of § 424.36(b), (c), or (d) 

apply. The statutory authority requiring 

a beneficiary’s signature on a claim 

submitted by a provider is located in 

section 1835(a) and in 1814(a) of the 


pwalker on PROD1PC71 with NOTICES